Does Dr. SAMER AL HADIDI have financial conflicts of interest?

Dr. SAMER AL HADIDI (M.D) has received a total of $28,788 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $28,788 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SAMER AL HADIDI?

According to CMS Open Payments data, Dr. SAMER AL HADIDI received funding from GENZYME CORPORATION ($9,222), JANSSEN BIOTECH ($7,086), and JANSSEN SCIENTIFIC AFFAIRS ($5,343).

Does Dr. SAMER AL HADIDI receive research grants or speaking fees?

Dr. SAMER AL HADIDI has received $28,788 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SAMER AL HADIDI

M.DReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: DALLAS, TX 75390

NPI Number: 1245670173

LIFETIME INDUSTRY VALUE

$28,788

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AL HADIDI is a verified Internal Medicine, Hematology & Oncology practitioner based in DALLAS, TX.

Between 2021 and 2025, Dr. AL HADIDI had an overall industry promotional and research financial footprint of $28,788 as recorded in the federal CMS Open Payments database.

$28,788 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL HADIDI's primary funding source is GENZYME CORPORATION, which accounts for $9,222 (representing 32% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION

Rank 1

$9,222

32%

JANSSEN BIOTECH

Rank 2

$7,086

24.6%

JANSSEN SCIENTIFIC AFFAIRS

Rank 3

$5,343

18.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.